- Home
- GROY vs LAB Comparison
GROY vs LAB Comparison
Compare GROY & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- LAB
- Stock Information
- Founded
- GROY 2020
- LAB 1999
- Country
- GROY Canada
- LAB United States
- Employees
- GROY N/A
- LAB N/A
- Industry
- GROY
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- GROY
- LAB Industrials
- Exchange
- GROY Nasdaq
- LAB Nasdaq
- Market Cap
- GROY 322.2M
- LAB 372.1M
- IPO Year
- GROY 2021
- LAB 2011
- Fundamental
- Price
- GROY $2.26
- LAB $1.22
- Analyst Decision
- GROY Strong Buy
- LAB Buy
- Analyst Count
- GROY 3
- LAB 2
- Target Price
- GROY $3.67
- LAB $2.50
- AVG Volume (30 Days)
- GROY 2.5M
- LAB 2.1M
- Earning Date
- GROY 08-12-2025
- LAB 07-30-2025
- Dividend Yield
- GROY N/A
- LAB N/A
- EPS Growth
- GROY N/A
- LAB N/A
- EPS
- GROY N/A
- LAB N/A
- Revenue
- GROY $10,347,000.00
- LAB $169,687,000.00
- Revenue This Year
- GROY $88.55
- LAB N/A
- Revenue Next Year
- GROY $52.87
- LAB $12.18
- P/E Ratio
- GROY N/A
- LAB N/A
- Revenue Growth
- GROY 99.94
- LAB 33.86
- 52 Week Low
- GROY $1.16
- LAB $0.92
- 52 Week High
- GROY $2.49
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- GROY 66.38
- LAB 60.35
- Support Level
- GROY $2.16
- LAB $1.02
- Resistance Level
- GROY $2.49
- LAB $1.59
- Average True Range (ATR)
- GROY 0.12
- LAB 0.09
- MACD
- GROY 0.01
- LAB 0.02
- Stochastic Oscillator
- GROY 63.28
- LAB 39.34
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.